Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:


Last Updated: January 27, 2023


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

US Court Litigation for HERCEPTIN HYLECTA

Patent Trial and Appeal Board Cases for HERCEPTIN HYLECTA

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
10,016,440 See Plans and Pricing 2016-01-19 201 See Plans and Pricing See Plans and Pricing
10,378,058 See Plans and Pricing 2018-04-24 201 See Plans and Pricing See Plans and Pricing
10,444,235 See Plans and Pricing 2017-03-10 201 See Plans and Pricing See Plans and Pricing
7,807,799 Hospira, Inc. See Plans and Pricing 2016-09-16 09-16-2016 Fahrner et al Inter partes review See Plans and Pricing 03-15-2017 See Plans and Pricing
8,420,081 See Plans and Pricing 2017-12-20 Wolfgang FRAUNHOFER et al 106 See Plans and Pricing Wolfgang FRAUNHOFER et al See Plans and Pricing
8,591,897 Celltrion, Inc. et al. See Plans and Pricing 2017-02-21 02-21-2017 Inter partes review See Plans and Pricing See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.